No search results mention this gene or its associated antibody.
The provided sources focus on human antibodies (e.g., COVID-19 monoclonal antibodies, HIV antibodies, malaria antibodies) and general antibody biology.
Plant-specific antibodies or research tools for Arabidopsis genes are not covered in the materials.
To obtain authoritative information about "At5g16640 Antibody," consider the following steps:
| Resource | Focus Area | Link |
|---|---|---|
| TAIR (Arabidopsis Information Resource) | Gene annotations, protein data, and antibody suppliers | www.arabidopsis.org |
| UniProt | Protein sequence and functional data | www.uniprot.org |
| NCBI Protein Database | Antibody validation studies | www.ncbi.nlm.nih.gov/protein |
Hypothetical Function: Genes with identifiers like At5g16640 often encode uncharacterized proteins. If this gene is under study, its antibody might be a custom reagent developed for specific research.
Key Journals: The Plant Cell, Plant Physiology, or Molecular Plant may publish studies using such antibodies.
While no data exists for At5g16640, the provided sources highlight critical antibody properties that may apply to plant antibodies:
Antibodies are Y-shaped proteins with variable regions for antigen binding .
Engineering strategies (e.g., affinity maturation) can enhance specificity and stability .
At5g16640 is an Arabidopsis thaliana gene identifier that encodes a protein involved in plant cellular processes. Based on research with similar Arabidopsis proteins, antibodies against At5g16640 enable critical investigations into protein localization, expression levels, and protein-protein interactions. These antibodies allow researchers to explore the protein's role in plant development and stress responses, similar to investigations of disease resistance proteins like SNC1 .
The development of specific antibodies against plant proteins like At5g16640 facilitates:
Direct visualization of protein distribution across different plant tissues
Quantification of protein expression under various experimental conditions
Identification of interacting protein partners through immunoprecipitation
Analysis of post-translational modifications that regulate protein function
Thorough validation is essential for ensuring antibody reliability in plant protein research:
Genetic validation approaches:
Test antibody against wild-type and knockout/knockdown lines
Observe reduced or absent signal in plants where At5g16640 expression is eliminated
Confirm enhanced detection in overexpression lines
Compare with transgenic lines expressing tagged versions (e.g., GFP/YFP fusions) similar to the CPR1-eYFP and ABA1-GFP fusion protein validations
Biochemical validation methods:
Pre-absorption test: Incubate antibody with purified antigen before immunodetection
Competition assays: Verify signal reduction with increasing concentrations of purified protein
Western blot analysis: Confirm single band at expected molecular weight
| Validation Method | Expected Result | Controls Required | Common Pitfalls |
|---|---|---|---|
| Western blot | Band at predicted MW | Knockout/overexpression samples | Cross-reactivity with related proteins |
| Immunofluorescence | Specific cellular localization | Secondary antibody-only control | Non-specific background in certain tissues |
| IP-MS | At5g16640 peptides identified | IgG control IP | Contamination from abundant proteins |
Effective protein extraction is critical for successful antibody-based detection of plant proteins:
Extraction buffer optimization:
Base buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA
Detergents: 0.5-1% Triton X-100 or NP-40 for membrane-associated proteins
Protease inhibitors: Complete cocktail with PMSF
Use TRI reagent for efficient protein isolation as demonstrated in related plant protein studies
Plant-specific extraction considerations:
Address interfering compounds with PVPP or PVP in extraction buffer
Remove abundant proteins (RuBisCO) using fractionation methods
Consider cellular compartmentalization of target protein
Minimize proteolytic degradation through rapid processing at 4°C
Tissue selection recommendations:
Harvest at consistent developmental stages for reproducibility
Flash freeze samples in liquid nitrogen immediately after collection
Consider circadian effects on protein expression levels
Optimizing Western blot protocols for plant proteins requires addressing several challenges:
Sample preparation:
Standardize protein concentration (20-50 μg total protein per lane)
Denature samples at appropriate temperature (70-95°C) in sample buffer
Include reducing agents (DTT or β-mercaptoethanol) to break disulfide bonds
Consider native vs. denaturing conditions based on antibody epitope
Blotting parameters:
Select appropriate membrane type (PVDF for general use, nitrocellulose for low background)
Optimize transfer conditions (wet transfer often provides better results for plant proteins)
Block with 5% BSA or non-fat milk (BSA preferred for phospho-detection)
Test antibody dilutions systematically (typically 1:500 to 1:5000)
Detection optimization:
Extend primary antibody incubation (overnight at 4°C often improves signal)
Increase wash stringency to reduce background
Select detection method based on abundance (chemiluminescence for low abundance)
Successful immunoprecipitation of plant proteins requires specialized approaches:
Pre-clearing strategies:
Pre-clear lysates with beads alone to reduce non-specific binding
Block beads with irrelevant protein (BSA) before antibody coupling
Use plant-specific blocking agents during incubation steps
Antibody coupling approaches:
Direct coupling to activated beads provides cleaner results than protein A/G
Cross-link antibody to beads to prevent antibody leaching
Determine optimal antibody-to-bead and antibody-to-lysate ratios empirically
Elution methods:
Gentle elution with excess epitope peptide for native protein recovery
Low pH glycine buffer (pH 2.8) with immediate neutralization
SDS elution for maximum recovery when protein function is not required
Verification approaches:
Confirm successful IP by Western blot of eluted material
Compare with IgG control to identify non-specific binding
Validate results with reciprocal IP using known interacting partners
Investigating protein-protein interactions in plant immunity pathways requires sophisticated immunological approaches:
Co-immunoprecipitation strategies:
Use At5g16640 antibody to pull down protein complexes from plant tissues
Compare interactomes under normal vs. infection conditions
Implement crosslinking prior to extraction for transient interactions
Identify interaction partners by mass spectrometry
Similar to studies of CPR1 and its association with the transcriptional corepressor TPR1 , At5g16640 antibodies can reveal how protein complexes dynamically form during immune responses. These approaches can detect:
Changes in interaction partners during pathogen challenge
Post-translational modifications affecting complex formation
Subcellular relocalization during immune activation
Proximity labeling applications:
Combine with BioID or APEX2 proximity labeling
Use antibody validation alongside proximity labeling results
Create interaction maps under different stress conditions
Post-translational modifications (PTMs) can significantly impact antibody detection of plant proteins:
Effects of common PTMs on antibody binding:
Phosphorylation: Can create or mask epitopes
Ubiquitination: Alters protein conformation and accessibility
SUMOylation: Changes epitope exposure
Strategies for comprehensive detection:
Develop modification-specific antibodies similar to phospho-ATG16L1 antibody
Use phosphatase treatment to compare modified vs. unmodified detection
Apply PTM-enrichment methods before immunodetection
Combine general protein antibodies with modification-specific antibodies
Experimental approach to assess PTM impact:
| PTM Type | Detection Strategy | Sample Treatment | Control Approach |
|---|---|---|---|
| Phosphorylation | Phospho-specific antibody | Lambda phosphatase treatment | Phosphatase inhibitor control |
| Ubiquitination | Anti-ubiquitin co-detection | DUB treatment | Proteasome inhibitor treatment |
| SUMOylation | SUMO-specific co-detection | SENP treatment | SUMO protease inhibitor control |
Development of phospho-specific antibodies follows similar principles to those used successfully for ATG16L1 :
Phospho-site identification:
Perform in silico analysis to predict potential phosphorylation sites
Conduct mass spectrometry to identify actual phosphorylation sites
Select sites with regulatory significance based on conservation
Antibody development strategy:
Design phospho-peptides with the phosphorylated residue centrally positioned
Implement dual-purification: negative selection with non-phosphorylated peptide followed by positive selection with phosphorylated peptide
Test monoclonal antibody development for highest specificity
Validation approach:
Compare detection in untreated vs. phosphatase-treated samples
Conduct peptide competition assays with phospho and non-phospho peptides
Test against phosphomimetic (S/T to D/E) and phospho-dead (S/T to A) mutants
Monitor rapid signaling events during stress responses
Detect early stages of protein activation
Quantify pathway activation in response to specific stimuli
Analyze spatial distribution of active protein in different tissues
Cross-reactivity presents common challenges when working with plant antibodies:
Epitope mapping and antibody refinement:
Identify minimal epitope sequences recognized by the antibody
Compare epitope sequence against proteome databases to identify potential cross-reactive proteins
Design blocking peptides for cross-reactive epitopes
Consider epitope-specific affinity purification of antibodies
Sample preparation strategies:
Implement subcellular fractionation to reduce sample complexity
Use size exclusion or ion exchange chromatography as pre-fractionation steps
Apply immunodepletion of known cross-reactive proteins
Cross-reactivity resolution workflow:
Identify cross-reactive bands by comparing wild-type and knockout samples
Determine molecular weights of cross-reactive proteins
Search protein databases for related proteins at those molecular weights
Pre-incubate antibody with blocking peptides before use
Chromatin immunoprecipitation with plant proteins requires specialized approaches:
Plant-specific ChIP optimization:
Crosslinking: Test multiple formaldehyde concentrations (1-3%) and incubation times
Tissue disruption: Use grinding in liquid nitrogen followed by nuclear isolation
Sonication: Optimize cycles for plant tissues (typically more cycles than animal samples)
Fragment size verification: Aim for 200-500 bp fragments
Antibody considerations for plant ChIP:
Validate antibody against tagged protein controls in preliminary experiments
Confirm specificity using ChIP-Western blots
Test antibody performance in preliminary ChIP-qPCR before proceeding to sequencing
Use higher antibody concentrations than for standard animal ChIP protocols
ChIP-seq data analysis for plant samples:
Implement input normalization accounting for repetitive regions in plant genomes
Apply bioinformatic filtration of chloroplast and mitochondrial DNA
Consider plant-specific genomic features during peak calling
Validate findings with orthogonal methods (e.g., reporter assays)
The successful application of antibodies in plant ChIP studies allows researchers to:
Map protein binding sites across the genome
Identify target genes regulated by the protein of interest
Characterize chromatin modifications associated with protein binding
Discover novel regulatory mechanisms in plant transcriptional networks